185 related articles for article (PubMed ID: 33119885)
1. Brain energy metabolism and multiple sclerosis: progress and prospects.
Park SJ; Choi JW
Arch Pharm Res; 2020 Oct; 43(10):1017-1030. PubMed ID: 33119885
[TBL] [Abstract][Full Text] [Related]
2. An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.
Zahoor I; Rui B; Khan J; Datta I; Giri S
Cell Mol Life Sci; 2021 Apr; 78(7):3181-3203. PubMed ID: 33449145
[TBL] [Abstract][Full Text] [Related]
3. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances.
Liu Z; Waters J; Rui B
Biomed J; 2022 Aug; 45(4):594-606. PubMed ID: 35042018
[TBL] [Abstract][Full Text] [Related]
5. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs associated with the pathogenesis of multiple sclerosis.
Huang Q; Xiao B; Ma X; Qu M; Li Y; Nagarkatti P; Nagarkatti M; Zhou J
J Neuroimmunol; 2016 Jun; 295-296():148-61. PubMed ID: 27235360
[TBL] [Abstract][Full Text] [Related]
8. The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosis.
Vanderlocht J; Hellings N; Hendriks JJ; Stinissen P
Crit Rev Immunol; 2007; 27(1):1-13. PubMed ID: 17430093
[TBL] [Abstract][Full Text] [Related]
9. The role of mitochondria in axonal degeneration and tissue repair in MS.
van Horssen J; Witte ME; Ciccarelli O
Mult Scler; 2012 Aug; 18(8):1058-67. PubMed ID: 22723572
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis as a vascular disease.
Minagar A; Jy W; Jimenez JJ; Alexander JS
Neurol Res; 2006 Apr; 28(3):230-5. PubMed ID: 16687046
[TBL] [Abstract][Full Text] [Related]
11. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.
Yun JW; Cvek U; Kilgore PCSR; Tsunoda I; Omura S; Sato F; Zivadinov R; Ramanathan M; Minagar A; Alexander JS
Life Sci; 2019 Jul; 229():116-123. PubMed ID: 31082401
[TBL] [Abstract][Full Text] [Related]
12. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Klotz L; Eschborn M; Lindner M; Liebmann M; Herold M; Janoschka C; Torres Garrido B; Schulte-Mecklenbeck A; Gross CC; Breuer J; Hundehege P; Posevitz V; Pignolet B; Nebel G; Glander S; Freise N; Austermann J; Wirth T; Campbell GR; Schneider-Hohendorf T; Eveslage M; Brassat D; Schwab N; Loser K; Roth J; Busch KB; Stoll M; Mahad DJ; Meuth SG; Turner T; Bar-Or A; Wiendl H
Sci Transl Med; 2019 May; 11(490):. PubMed ID: 31043571
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
14. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
[TBL] [Abstract][Full Text] [Related]
15. Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects.
Pender MP; Wolfe NP
Intern Med J; 2002 Nov; 32(11):554-63. PubMed ID: 12412939
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
Stinissen P; Raus J; Zhang J
Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
Haider L
Oxid Med Cell Longev; 2015; 2015():725370. PubMed ID: 26106458
[TBL] [Abstract][Full Text] [Related]
18. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
19. Progress in understanding the pathophysiology of multiple sclerosis.
Zéphir H
Rev Neurol (Paris); 2018 Jun; 174(6):358-363. PubMed ID: 29680179
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
